US$ 26.65
semaglutide pediatric dosing Dosage Chart for Weight Loss and Type 2 Diabetes Understanding Dosage Charts for Semaglutide
Description
Feng P, Zhang X, Li D, et al

[DOI] [PubMed] [Google Scholar] 76.McGeer E

Its only approved for people living with type 2 diabetes

Keeping abreast of these developments is critical as they pave the way for a new paradigm in treatment

An indirect comparison of data by Novo Nordisk from the STEP 1 trial and the SCALE trial of daily GLP-1 agonist liraglutide suggested 5.81% more weight loss with semaglutide than liraglutide at 68 weeks, and this was backed up by data from the STEP 8 trial, which directly compared the two treatments[1,3,4]

Weight reduction achieved through Ozempic treatmenttypically around 4-6% of body weight at doses used for type 2 diabetesmay help reduce cardiovascular burden
